Cepheid's tuberculosis test detects drug resistance

2020 07 16 20 00 5298 Cepheid Xpert Mtb 400

Cepheid has launched a new test that performs drug-resistant tuberculosis profiling in less than 90 minutes.

The company's Xpert Mycobacterium tuberculosis/extensively drug-resistant (MTB/XDR) test identifies tuberculosis that is resistant to first- and second-line drugs, particularly the disease's most complicated form -- XDR-TB -- the company said.

Xpert MTB/XDR runs on Cepheid GeneXpert systems which already process the company's Xpert MTB/rifampin (RIF) and Xpert MTB/RIF Ultra tests for tuberculosis diagnosis and identification of resistance to the drug rifampicin, according to the firm.

Page 1 of 2
Next Page